🇺🇸 FDA
Patent

US 8008021

N-terminal truncation of cardiac troponin subunits and their roles in cardiovascular disease

granted A61KA61K38/1719A61P

Quick answer

US patent 8008021 (N-terminal truncation of cardiac troponin subunits and their roles in cardiovascular disease) held by Evanston Northwestern Healthcare expires Mon Aug 25 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Evanston Northwestern Healthcare
Grant date
Tue Aug 30 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 25 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K38/1719, A61P, A61P9/00